Albany NY, United States: Immune repertoire is the sum of T cell receptors and B cell receptors that make an organism’s adaptive immune system.
Albany NY, United States: Immune repertoire is the sum of T cell receptors and B cell receptors that make an organism’s adaptive immune system. It is extensively used in biomarker discovery to improve the success rate and cost-effectiveness of rational drug development. Advancements in next generation sequencing (NGS) have facilitated the development of a prevailing new technology known as immune repertoire sequencing for probing the complimentary determining region of these receptors. Immune repertoire sequencing targets T and B-lymphocytes and utilizes the 5’ Rapid Amplification of cDNA Ends (RACE) Technology.
Request a report brochure to gain comprehensive insights at:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=84207
Global Immune Repertoire Sequencing Market: Trends, Drivers, Restraints
- Increase in government support for pharmacogenomics-based drug recovery is the major driver of the global immune repertoire sequencing market. Additionally, rapid rise in numerous therapeutic areas such as infectious diseases, cardiology, oncology, and pain management boosts the growth of the global market.
- Agreements & partnerships among manufacturers is another key factor projected to contribute to the growth of the global immune repertoire sequencing market during the forecast period. For instance, in March 2018, ArcherDX and Ambry Genetics announced a partnership agreement to develop promising and innovative immunotherapies.
- Increase in demand for personalized medicine is expected to propel the global immune repertoire sequencing market in the next few years, as personalized medicine uses an individual’s genetic makeup to direct the decisions made about the prevention, diagnosis, and cure of diseases.
- Launch of novel products by key players and advancements in research & development are likely to fuel the growth of the global immune repertoire sequencing market in the near future. In 2017, ArcherDX launched Archer Immunoverse B Cell Receptor (BCR) assays to characterize the human B cell repertoire. According to a study published by Cold Spring Harbor Laboratory in 2017, researchers from the Stanford University applied immune repertoire sequencing to identify disease-related signatures in the immune systems of patients with systemic sclerosis-related pulmonary hypertension, which is a rare chronic autoimmune disease that affects the connective tissue. Hence, increase in research on immune repertoire sequencing is projected to augment the global immune repertoire sequencing market.
Request for Covid-19 Impact Analysis:
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=84207
- However, distinctive biological variations from the errors and the bias introduced in various different steps act as major restraints of the global immune repertoire sequencing market. Moreover, differences of data generation and processing in different laboratories are anticipated to hamper the growth of the global immune repertoire sequencing market during the forecast period.
COVID -19 Impact on Global Immune Repertoire Sequencing Market
- The COVID-19 pandemic has had a significant effect on the global immune repertoire sequencing market due to undermining clinical trials, inadequate supply chain management & raw material storage, and patient incompliance. Moreover, decline in funding by governments due to the pandemic has negatively affected the global immune repertoire sequencing market.
North America to Dominate Global Immune Repertoire Sequencing Market
- In terms of region, North America is expected to dominate the global immune repertoire sequencing marked during the forecast period. The U.S. is likely to dominate the market in the region due to increase in demand for immunotherapy for cancer and other infectious diseases.
For any Queries Related with the Report, Ask an Analyst:
https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84207
- Europe was the second largest market for immune repertoire sequencing in 2020 due to funding by governments and increase in health care expenditure
- The market in Asia Pacific, primarily in Japan and China, is projected to witness significant growth due to international collaborations for immune repertoire sequencing and developments.
- However, Middle East & Africa is expected to be the least attractive market for immune repertoire sequencing due to lack of skilled personnel and Internet access limitations for data analysis
Key players in the global immune repertoire sequencing market are:
- Adaptive Biotechnologies
- Thermo Fisher Scientific
- Pacific Biosciences
- Illumina, Inc.
- Juno Therapeutics
- F. Hoffmann La-Roche AG
- CD Genomics
- QIAGEN N.V.
- Atreca, Inc.
- Oxford Nanopore Technologies, Ltd.
- ArcherDX, Inc.
- Abvitro (Now Juno Therapeutics)
- Agilent Technologies
- Irepertoire, Inc.
- Takara Bio, Inc.
- Others
More Trending Reports by Transparency Market Research:
Next-generation Immune Repertoire Sequencing Market: Profiling of T- and B-cell receptor repertoires in an individual has led to a vast repository of information on acquired immunity against various microorganisms. Next-generation immune repertoire sequencing has allowed researchers to make sophisticated immuno-bioinformatics analyses.
Chronic Immune Thrombocytopenia Market: The chronic immune thrombocytopenia market is extrapolated to bring good growth prospects across the assessment period of 2021-2031. The increasing prevalence of chronic immune thrombocytopenia among a considerable chunk of the global populace will invite promising growth during the tenure of 2021-2031.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453